Zoom (ZM) Zoomtopia 2024 summary

Finance and strategy updates

• Introduced new CFO, Michelle Chang, with extensive transformation experience from Microsoft.

• Announced AI Companion 2.0 as a personal assistant, included at no extra cost, with monetized custom AI and vertical solutions for healthcare and education.

• Projected total addressable market to reach $235B by 2028, driven by organic and inorganic expansion, with $56B attributed to new products.

• Customers with three or more products now contribute 66% of annual recurring revenue, with reduced churn and increased contract lengths.

• Japan is now the top international market, and verticals like healthcare and education are rising due to AI investments.

AI innovation and product strategy

• AI is the top investment priority, using a federated approach with models from OpenAI, Anthropic, Meta, and in-house, optimizing for cost and quality.

• AI Companion 2.0 offers contextual, action-oriented assistance across the platform, with strong adoption and improved accuracy.

• Custom AI Companion add-ons and AI Studio enable organizations to tailor AI to their data and workflows, supporting integration with third-party apps.

• Personalization features include a personal coach and custom avatars, with vertical applications for education and healthcare.

• AI Companion is positioned as an orchestrator across collaboration workflows, integrating with external tools and maintaining a unified memory.

Operational efficiency and financial model

• Shifted 91% of traffic to colocation data centers, reducing AI Companion COGS per user by over 30% in two quarters.

• FY25 guidance: 79% gross margin, 39% non-GAAP operating margin, and 35% free cash flow margin.

• Updated long-term model: 80% gross profit, increased R&D to 12-13%, reduced sales/marketing to 25-26%, and G&A to 7-8%, targeting 33-36% operating profit.

• Stock-based compensation expected to decline to under 12% by FY28, with gross dilution rate dropping below 2.75%.

• $1.5B buyback authorization in place, with $438M executed in H1, balancing capital allocation between growth and shareholder returns.